FDA reform reprise in 105th Congress planned by industry groups and House Republicans.
Executive Summary
FDA REFORM REPRISE IN 105th CONGRESS IS PLANNED by industry trade groups and the Republican House leadership. House Commerce/Oversight Subcommittee Chairman Barton (R-Tex.) expressed the Republican House leadership interest in comments to a medical device manufacturers meeting in Seattle on Sept. 16. "There's no reason we couldn't [re-introduce] this bill in early January," and put it on a fast legislative track, Barton declared.